Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
- PMID: 21168133
- PMCID: PMC3079565
- DOI: 10.1016/j.fertnstert.2010.11.036
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Abstract
Objective: To perform a review and metaanalysis of the studies evaluating the status of serum inflammatory markers in women with polycystic ovary syndrome (PCOS).
Design: Systematic review and metaanalysis of articles published in English before January 2010 and identified using the PubMed search engine.
Setting: Academic hospital.
Patient(s): Women with PCOS and appropriate controls.
Intervention(s): Measurement of serum concentrations of inflammatory markers by high-sensitivity techniques.
Main outcome measure(s): Metaanalyses of the mean difference in serum C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) concentrations among patients with PCOS and appropriate controls, applying random-effects models to limit interstudy variability, and using appropriate estimates of evidence dissemination bias.
Result(s): Metaanalysis of the 31 articles meeting inclusion criteria showed that circulating CRP was 96% higher in women with PCOS compared to controls (95% confidence interval, 71%-122%; z = 7.32) without evidence of dissemination bias (Egger's regression intercept, 0.45; 95% confidence interval, -2.30 to 3.21). These findings persisted after excluding five studies with mismatches in body mass, frequency of obesity, or both, between women with PCOS and controls. Metaanalyses involving 10 studies of IL-6, and nine studies of TNF-α revealed no statistically significant differences between PCOS and controls.
Conclusion(s): Women with PCOS exhibit an elevation in circulating CRP that is independent of obesity. This finding corroborates existing molecular evidence of the chronic low-grade inflammation that may underpin the pathogenesis of this disorder.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis.Fertil Steril. 2011 Oct;96(4):e158. doi: 10.1016/j.fertnstert.2011.07.1098. Epub 2011 Aug 11. Fertil Steril. 2011. PMID: 21839436 No abstract available.
References
-
- Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 2003;24:278–301. - PubMed
-
- González F, Minium J, Rote NS, Kirwan JP. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:5337–42. - PubMed
-
- González F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:336–40. - PubMed
-
- González F, Rote NS, Minium J, Kirwan JP. Increased activation of nuclear factor κB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1508–12. - PubMed
-
- González F, Rote NS, Minium J, Kirwan JP. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome. J Endocrinol. 2006;188:521–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
